← Adagene Inc.

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $1.5m $480k $701k $10.2m $9.3m $18.1m $103k $7.7m
Research And Development — $16.2m $33.5m $68.1m $81.3m $36.6m $28.8m $22.0m
Operating expenses:
Operating Income (Loss) ($17.3m) ($19.2m) ($43.2m) ($72.4m) ($83.9m) ($23.7m) ($36.0m) ($21.4m)
Additional Financial Items
Foreign Currency Transaction Gain (Loss), before Tax $13k $22k ($645k) ($603k) $2.6m $1.4m ($906k) $1.3m
Income (Loss) from Continuing Operations before Income Taxes, Domestic — — — — — — — ($1.6m)
Other Operating Income — — — — ($78.8m) $3.5m ($32.6m) ($17.4m)
Licensing and collaboration revenue $1.5m $480k $701k $10.2m $9.3m $18.1m $103k $7.7m
Loss from operations ($17.3m) ($19.2m) ($43.2m) ($72.4m) ($83.9m) ($23.7m) ($36.0m) ($21.4m)
Interest and investment income — — — — $378k $4.3m $3.8m $2.3m
Other income, net $902k $723k $972k $1.8m $2.2m $1.8m $467k $324k
Foreign exchange gain (loss), net $13k $22k ($645k) ($603k) $2.6m $1.4m ($906k) $1.3m
Change in fair value of warrant liabilities $534k $1.2m $0 — — — — $48k
Loss before income tax ($15.3m) ($16.4m) ($42.4m) ($71.5m) ($79.5m) ($17.3m) ($33.4m) ($17.9m)
Net loss attributable to Adagene Inc.'s shareholders ($15.3m) ($16.4m) ($42.4m) ($73.2m) ($80.0m) ($18.9m) ($33.4m) ($17.6m)
Foreign currency translation adjustments, net of nil tax ($11k) $66k ($6k) $257k ($755k) ($951k) $1.3m ($1.4m)
Net loss attributable to ordinary shareholders ($14.3m) ($16.7m) ($42.6m) ($73.2m) ($80.0m) ($18.9m) ($33.4m) ($17.6m)
Basic (in shares) $15.2m $15.2m $16.0m $50.0m $54.1m $54.7m $56.3m $59.0m
Diluted (in shares) $15.2m $15.2m $16.0m $50.0m $54.1m $54.7m $56.3m $59.0m
Diluted EPS — — — ($1.82) ($1.85) ($0.44) ($0.74) —
Diluted NI Availto Com Stockholders ($15.3m) ($16.4m) ($42.4m) ($73.2m) ($80.0m) ($18.9m) ($33.4m) ($17.6m)
Gain On Sale Of Security — — — — $2.6m $1.4m ($906k) $1.4m
Interest Income — — — — $378k $4.3m $3.8m $2.3m
Interest Income Non Operating — — — — $378k $4.3m $3.8m $2.3m
Net Income From Continuing And Discontinued Operation ($15.3m) ($16.4m) ($42.4m) ($73.2m) ($80.0m) ($18.9m) ($33.4m) ($17.6m)
Net Income From Continuing Operation Net Minority Interest ($15.3m) ($16.4m) ($42.4m) ($73.2m) ($80.0m) ($18.9m) ($33.4m) ($17.6m)
Net Interest Income — — — — ($316k) $3.2m $2.9m $1.8m
Normalized EBITDA — — — — ($79.9m) ($16.4m) ($30.7m) ($18.2m)
Normalized Income — — — — ($81.9m) ($20.0m) ($32.5m) ($19.0m)
Other Gand A — $3.4m $10.3m $14.4m $11.9m $8.7m $7.3m $7.1m
Otherunder Preferred Stock Dividend — — — $29k $0 $0 — —
Reconciled Depreciation — — — — $1.4m $1.2m $939k $590k
Selling General And Administration — $3.4m $10.3m $14.4m $11.9m $8.7m $7.3m $7.1m
Tax Effect Of Unusual Items — — — — $639k $362k ($476) $23k
Tax Provision — — — $1.7m $459k $1.7m ($18k) ($298k)
Tax Rate For Calcs — — — — $0 $0 $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest ($15.3m) ($16.4m) ($42.4m) ($71.5m) ($79.5m) ($17.3m) ($33.4m) ($17.9m)
Total comprehensive loss attributable to Adagene Inc.'s shareholders ($15.3m) ($16.4m) ($42.4m) ($72.9m) ($80.7m) ($19.9m) ($32.2m) ($19.0m)
Total Unusual Items — — — — $2.6m $1.4m ($906k) $1.4m
Total Unusual Items Excluding Goodwill — — — — $2.6m $1.4m ($906k) $1.4m
Pre-Tax Income ($15.3m) ($16.4m) ($42.4m) ($71.5m) ($79.5m) ($17.3m) ($33.4m) ($17.9m)
Net Income Continuous Operations ($15.3m) ($16.4m) ($42.4m) ($73.2m) ($80.0m) ($18.9m) ($33.4m) ($17.6m)
Net Income (Loss) Attributable to Parent ($15.3m) ($16.4m) ($42.4m) ($73.2m) ($80.0m) ($18.9m) ($33.4m) ($17.6m)
Net Income (Loss) Available to Common Stockholders, Basic ($14.3m) ($16.7m) ($42.6m) ($73.2m) ($80.0m) ($18.9m) ($33.4m) ($17.6m)
Net Income Including Noncontrolling Interests ($15.3m) ($16.4m) ($42.4m) ($73.2m) ($80.0m) ($18.9m) ($33.4m) ($17.6m)
Earnings Per Share, Basic ($0.94) ($1.10) ($2.67) ($1.46) ($1.48) ($0.35) ($0.59) ($0.30)
Earnings Per Share, Diluted ($0.94) ($1.10) ($2.67) ($1.46) ($1.48) ($0.35) ($0.59) ($0.30)
Weighted Average Number of Shares Outstanding, Basic 15.2m 15.2m 16.0m 50.0m 54.1m 54.7m 56.3m 59.0m
Basic Average Shares — — — $40.0m $43.3m $43.8m $45.0m —
Diluted Average Shares — — — $40.0m $43.3m $43.8m $45.0m —
Weighted Average Number of Shares Outstanding, Diluted 15.2m 15.2m 16.0m 50.0m 54.1m 54.7m 56.3m 59.0m
Research and Development Expense — $16.2m $33.5m $68.1m $81.3m $36.6m $28.8m $22.0m
Research and development expenses ($16.1m) ($16.2m) ($33.5m) ($68.1m) ($81.3m) ($36.6m) ($28.8m) ($22.0m)
General and Administrative Expense — $3.4m $10.3m $14.4m $11.9m $8.7m $7.3m $7.1m
Administrative expenses ($2.8m) ($3.4m) ($10.3m) ($14.4m) ($11.9m) ($8.7m) ($7.3m) ($7.1m)
Interest Expense (non-operating) — — — — $693k $1.1m $852k $463k
Interest Expense ($91k) $138k $202k $364k $693k $1.1m ($852k) ($463k)
Current Income Tax Expense (Benefit) — — — $1.7m $503k $1.7m ($18k) ($298k)
Income tax benefit (expense) — — — ($1.7m) ($459k) ($1.7m) $18k $298k
Net Non Operating Interest Income Expense — — — — ($316k) $3.2m $2.9m $1.8m
Operating Expense — — — — $93.2m $41.8m $36.1m $29.1m
Other Income Expense — — — — $4.7m $3.3m ($440k) $1.7m
Other Non Operating Income Expenses $902k $723k $972k $1.8m $2.2m $1.8m $467k $324k
Income Tax Expense (Benefit) — — — $1.7m $459k $1.7m ($18k) ($298k)
Total Expenses — — — — $93.2m $41.8m $36.1m $29.1m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.